ESMO 2026 - DESTINY-Breast11: MRI Response with Dr. Jean-François Boileau

Dr. Jean-François Boileau reviews MRI findings from DESTINY-Breast11, highlighting tumour response with T-DXd followed by THP and the limitations of MRI in predicting pathological complete response in HER2-positive early breast cancer.